Literature DB >> 2138014

Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter?

W W Beatty1, D E Goodkin, D Hertsgaard, N Monson.   

Abstract

Patients with chronic progressive multiple sclerosis often perform more poorly on cognitive tasks than do patients with the relapsing-remitting form of this disease. Whether these differences reflect an independent influence of disease type on cognitive performance is uncertain. We used multiple regression techniques to determine how well performance on a number of tasks done poorly by groups of patients with multiple sclerosis could be predicted by disease type and its confounds: age, disease duration, and disability status as well as other demographic variables. Disease types were assigned longitudinally, based on serial neurological examinations at 6-month intervals over a minimum of 2 years. None of the demographic or clinical variables predicted cognitive performance with more than minimal accuracy. These findings fail to provide support for the assertion that disease type is an important independent determinant of cognitive impairment in multiple sclerosis.

Entities:  

Mesh:

Year:  1990        PMID: 2138014     DOI: 10.1001/archneur.1990.00530030081019

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  14 in total

1.  Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.

Authors:  Nadine Akbar; Kimia Honarmand; Nancy Kou; Anthony Feinstein
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

Review 2.  Cognitive dysfunctions in multiple sclerosis--a "multiple disconnection syndrome"?

Authors:  Pasquale Calabrese; Iris Katharina Penner
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 3.  The neuropsychology of multiple sclerosis: contributions of neuroimaging research.

Authors:  H A Wishart; L Flashman; A J Saykin
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

4.  Evolving expectations around early management of multiple sclerosis.

Authors:  Ralf Gold; Jerry S Wolinsky; Maria Pia Amato; Giancarlo Comi
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

5.  Cognition in the early stage of multiple sclerosis.

Authors:  Doreen Schulz; Bruno Kopp; Annett Kunkel; Jürgen H Faiss
Journal:  J Neurol       Date:  2006-04-11       Impact factor: 4.849

6.  Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction.

Authors:  E Stenager; L Knudsen; K Jensen
Journal:  Ital J Neurol Sci       Date:  1994-03

7.  The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.

Authors:  T A M Siepman; A C J W Janssens; I de Koning; C H Polman; J B Boringa; R Q Hintzen
Journal:  J Neurol       Date:  2008-05-20       Impact factor: 4.849

Review 8.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

9.  An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.

Authors:  Barth Wilsey; Thomas D Marcotte; Reena Deutsch; Holly Zhao; Hannah Prasad; Amy Phan
Journal:  J Pain       Date:  2016-06-07       Impact factor: 5.820

10.  Cognitive status in patients with multiple sclerosis in Lanzarote.

Authors:  María Yaiza Pérez-Martín; Pablo Eguia-Del Río; Montserrat González-Platas; Alejandro Jiménez-Sosa
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-30       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.